{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T02:51:03Z","timestamp":1791255063786,"version":"4.1.0"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T00:00:00Z","timestamp":1783728000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T00:00:00Z","timestamp":1791244800000},"content-version":"vor","delay-in-days":87,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["31970698"],"award-info":[{"award-number":["31970698"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012542","name":"Sichuan Provincial Science and Technology Support Program","doi-asserted-by":"publisher","award":["2023YFS0109"],"award-info":[{"award-number":["2023YFS0109"]}],"id":[{"id":"10.13039\/100012542","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Oncol."],"DOI":"10.1007\/s13402-026-01259-6","type":"journal-article","created":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T09:33:53Z","timestamp":1783762433000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["RNF114-PACSIN3 signaling axis promotes hepatocellular carcinoma progression by enhancing GLUT1 membrane retention and glucose uptake"],"prefix":"10.1007","volume":"49","author":[{"given":"Yue","family":"Song","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yilu","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qixiang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lan","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ge","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyi","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyu","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"You","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-0906-0178","authenticated-orcid":false,"given":"Yongxin","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,11]]},"reference":[{"issue":"6","key":"1259_CR1","doi-asserted-by":"publisher","first-page":"1598","DOI":"10.1016\/j.jhep.2022.08.021","volume":"77","author":"H Rumgay","year":"2022","unstructured":"H. Rumgay, M. Arnold, J. Ferlay, O. Lesi, C.J. Cabasag, J. Vignat et al., Global burden of primary liver cancer in 2020 and predictions to 2040. J. Hepatol. 77(6), 1598\u20131606 (2022)","journal-title":"J. Hepatol."},{"issue":"5930","key":"1259_CR2","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1126\/science.1160809","volume":"324","author":"MG Vander Heiden","year":"2009","unstructured":"M.G. Vander Heiden, L.C. Cantley, C.B. Thompson, Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation. Science. 324(5930), 1029\u20131033 (2009)","journal-title":"Science"},{"key":"1259_CR3","doi-asserted-by":"crossref","unstructured":"J. Feng, J. Li, L. Wu, Q. Yu, J. Ji, J. Wu et al., Emerging roles and the regulation of aerobic glycolysis in hepatocellular carcinoma. J. Experimental Clin. Cancer Res. 39 (1), (2020)","DOI":"10.1186\/s13046-020-01629-4"},{"key":"1259_CR4","doi-asserted-by":"crossref","unstructured":"Y. Tang, Y. Deng, J. Li, B. Chi, D. Xiong, R. He et al., Potential regulatory mechanism of overexpression of phosphatidylinositol glycan anchor biosynthesis class U on the glycolytic pathway in hepatocellular carcinoma. Gene 963 (2025)","DOI":"10.1016\/j.gene.2025.149603"},{"key":"1259_CR5","doi-asserted-by":"crossref","unstructured":"F. Wang, Y. Hu, H. Wang, P. Hu, H. Xiong, Z. Zeng et al., LncRNA FTO-IT1 promotes glycolysis and progression of hepatocellular carcinoma through modulating FTO-mediated N6-methyladenosine modification on GLUT1 and PKM2. J. Experimental Clin. Cancer Res. 42 (1), (2023)","DOI":"10.1186\/s13046-023-02847-2"},{"key":"1259_CR6","doi-asserted-by":"crossref","unstructured":"J. Zhong, L. Tian, Y. Gou, P. Zhao, X. Dong, M. Guo et al., BMP4 upregulates glycogen synthesis through the SMAD\/SLC2A1 (GLUT1) signaling axis in hepatocellular carcinoma (HCC) cells. Cancer Metabolism 11 (1), (2023)","DOI":"10.1186\/s40170-023-00310-6"},{"issue":"11","key":"1259_CR7","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1002\/cac2.12607","volume":"44","author":"J Cai","year":"2024","unstructured":"J. Cai, L. Song, F. Zhang, S. Wu, G. Zhu, P. Zhang et al., Targeting SRSF10 might inhibit M2 macrophage polarization and potentiate anti-PD\u20101 therapy in hepatocellular carcinoma. Cancer Commun. 44(11), 1231\u20131260 (2024)","journal-title":"Cancer Commun."},{"key":"1259_CR8","doi-asserted-by":"crossref","unstructured":"Y. Lu, J. Zhu, Y. Zhang, W. Li, Y. Xiong, Y. Fan et al., Lactylation-Driven IGF2BP3\u2010Mediated Serine Metabolism Reprogramming and RNA m6A\u2014Modification Promotes Lenvatinib Resistance in HCC. Adv. Sci. 11 (46), (2024)","DOI":"10.1002\/advs.202401399"},{"key":"1259_CR9","doi-asserted-by":"crossref","unstructured":"Z. Zhang, X. Li, F. Yang, C. Chen, P. Liu, Y. Ren et al., DHHC9-mediated GLUT1 S-palmitoylation promotes glioblastoma glycolysis and tumorigenesis. Nat. Commun. 12 (1), (2021)","DOI":"10.1038\/s41467-021-26180-4"},{"key":"1259_CR10","doi-asserted-by":"crossref","unstructured":"Z. Zhu, J. Sun, W. Xu, Q. Zeng, H. Feng, L. Zang et al., MGAT4A\/Galectin9-Driven N\u2010Glycosylation Aberration as a Promoting Mechanism for Poor Prognosis of Endometrial Cancer with TP53 Mutation. Adv. Sci. 11 (48), (2024)","DOI":"10.1002\/advs.202409764"},{"key":"1259_CR11","doi-asserted-by":"crossref","unstructured":"Y. Sheng, X. Jin, J. Xu, J. Gao, X. Du, D. Duan et al., Sequencing-based approach identified three new susceptibility loci for psoriasis. Nat. Commun. 5 (1), (2014)","DOI":"10.1038\/ncomms5331"},{"issue":"8","key":"1259_CR12","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1038\/cdd.2013.33","volume":"20","author":"J Han","year":"2013","unstructured":"J. Han, Y.L. Kim, K.W. Lee, N.G. Her, T.K. Ha, S. Yoon et al., ZNF313 is a novel cell cycle activator with an E3 ligase activity inhibiting cellular senescence by destabilizing p21WAF1. Cell. Death Differ. 20(8), 1055\u20131067 (2013)","journal-title":"Cell. Death Differ."},{"issue":"10","key":"1259_CR13","doi-asserted-by":"publisher","first-page":"1643","DOI":"10.2217\/fon.10.114","volume":"6","author":"G Narayan","year":"2010","unstructured":"G. Narayan, V.V. Murty, Integrative Genomic Approaches in Cervical Cancer: Implications for Molecular Pathogenesis. Future Oncol. 6(10), 1643\u20131652 (2010)","journal-title":"Future Oncol."},{"issue":"3","key":"1259_CR14","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1007\/s12072-015-9642-0","volume":"9","author":"D Wang","year":"2015","unstructured":"D. Wang, Z. Zhu, H. Jiang, J. Zhu, W. Cong, B. Wen et al., Multiple genes identified as targets for 20q13.12\u201313.33 gain contributing to unfavorable clinical outcomes in patients with hepatocellular carcinoma. Hep. Intl. 9(3), 438\u2013446 (2015)","journal-title":"Hep. Intl."},{"issue":"2","key":"1259_CR15","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1002\/cac2.12132","volume":"41","author":"Y Zhao","year":"2021","unstructured":"Y. Zhao, X. Liang, L. Wei, Y. Liu, J. Liu, H. Feng et al., RNF114 suppresses metastasis through regulation of PARP10 in cervical cancer cells. Cancer Commun. 41(2), 187\u2013191 (2021)","journal-title":"Cancer Commun."},{"issue":"2","key":"1259_CR16","doi-asserted-by":"publisher","first-page":"565","DOI":"10.7150\/jca.62033","volume":"13","author":"Z Feng","year":"2022","unstructured":"Z. Feng, L. Li, Q. Zeng, Y. Zhang, Y. Tu, W. Chen et al., RNF114 Silencing Inhibits the Proliferation and Metastasis of Gastric Cancer. J. Cancer. 13(2), 565\u2013578 (2022)","journal-title":"J. Cancer"},{"key":"1259_CR17","doi-asserted-by":"crossref","unstructured":"S. Liu, L. Gong, F. Huang, N. Xu, K. Yang, X. Liu et al., RNF114 facilitates the proliferation, stemness, and metastasis of colorectal cancer. Pathol. - Res. Pract. 248 (2023)","DOI":"10.1016\/j.prp.2023.154716"},{"key":"1259_CR18","doi-asserted-by":"crossref","unstructured":"L. Tang, Y. Ji, C. Ni, Z. Xu, Y. Shen, H. Lu et al., EIF4A3-Mediated Biogenesis of CircFADS1 Promotes the Progression of Hepatocellular Carcinoma via Wnt\/\u03b2\u2010Catenin Pathway. Adv. Sci. 12 (14), (2025)","DOI":"10.1002\/advs.202411869"},{"issue":"D1","key":"1259_CR19","doi-asserted-by":"publisher","first-page":"D1670","DOI":"10.1093\/nar\/gkae973","volume":"53","author":"S Jiang","year":"2025","unstructured":"S. Jiang, H. Li, L. Zhang, W. Mu, Y. Zhang, T. Chen et al., Generic Diagramming Platform (GDP): a comprehensive database of high-quality biomedical graphics. Nucleic Acids Res. 53(D1), D1670\u2013D1676 (2025)","journal-title":"Nucleic Acids Res."},{"key":"1259_CR20","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.neo.2022.01.001","volume":"25","author":"DS Chandrashekar","year":"2022","unstructured":"D.S. Chandrashekar, S.K. Karthikeyan, P.K. Korla, H. Patel, A.R. Shovon, M. Athar et al., UALCAN: An update to the integrated cancer data analysis platform. Neoplasia. 25, 18\u201327 (2022)","journal-title":"Neoplasia"},{"issue":"8","key":"1259_CR21","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1016\/j.neo.2017.05.002","volume":"19","author":"DS Chandrashekar","year":"2017","unstructured":"D.S. Chandrashekar, B. Bashel, S.A.H. Balasubramanya, C.J. Creighton, I. Ponce-Rodriguez, B.V.S.K. Chakravarthi et al., UALCAN: A Portal for Facilitating Tumor Subgroup Gene Expression and Survival Analyses. Neoplasia. 19(8), 649\u2013658 (2017)","journal-title":"Neoplasia"},{"issue":"24","key":"1259_CR22","doi-asserted-by":"publisher","first-page":"10202","DOI":"10.1158\/0008-5472.CAN-10-2607","volume":"70","author":"S Roessler","year":"2010","unstructured":"S. Roessler, H.-L. Jia, A. Budhu, M. Forgues, Q.-H. Ye, J.-S. Lee et al., A Unique Metastasis Gene Signature Enables Prediction of Tumor Relapse in Early-Stage Hepatocellular Carcinoma Patients. Cancer Res. 70(24), 10202\u201310212 (2010)","journal-title":"Cancer Res."},{"issue":"5","key":"1259_CR23","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.1002\/hep.24813","volume":"55","author":"SM Kim","year":"2012","unstructured":"S.M. Kim, S.-H. Leem, I.-S. Chu, Y.-Y. Park, S.C. Kim, S.-B. Kim et al., Sixty-five gene-based risk score classifier predicts overall survival in hepatocellular carcinoma. Hepatology. 55(5), 1443\u20131452 (2012)","journal-title":"Hepatology"},{"key":"1259_CR24","doi-asserted-by":"crossref","unstructured":"J. Ning, Y. Ye, H. Shen, R. Zhang, H. Li, T. Song et al., Macrophage-coated tumor cluster aggravates hepatoma invasion and immunotherapy resistance via generating local immune deprivation. Cell. Rep. Med. 5 (5), (2024)","DOI":"10.1016\/j.xcrm.2024.101505"},{"issue":"21","key":"1259_CR25","doi-asserted-by":"publisher","first-page":"7252","DOI":"10.1158\/1078-0432.CCR-04-0713","volume":"10","author":"RL Camp","year":"2004","unstructured":"R.L. Camp, M. Dolled Filhart, D.L. Rimm, A New Bio-Informatics Tool for Biomarker Assessment and Outcome-Based Cut-Point Optimization. Clin. Cancer Res. 10(21), 7252\u20137259 (2004)","journal-title":"Clin. Cancer Res."},{"key":"1259_CR26","doi-asserted-by":"crossref","unstructured":"Z. Wen, D. Luo, S. Wang, R. Rong, B.M. Evers, L. Jia et al., Deep Learning\u2013Based H-Score Quantification of Immunohistochemistry-Stained Images. Mod. Pathol. 37 (2), (2024)","DOI":"10.1016\/j.modpat.2023.100398"},{"key":"1259_CR27","doi-asserted-by":"crossref","unstructured":"R. Sun, A.M.J. Kim, A.A. Murray, S. Lim, N-Glycosylation Facilitates 4-1BB Membrane Localization by Avoiding Its Multimerization. Cells 11 (1), (2022)","DOI":"10.3390\/cells11010162"},{"key":"1259_CR28","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.biochi.2020.04.001","volume":"174","author":"EK Lodge","year":"2020","unstructured":"E.K. Lodge, J.D. Bell, E.M. Roloff, K.E. Hamilton, L.L. Louters, B.D. Looyenga, Pharmacologic inhibition of N-linked glycan trimming with kifunensine disrupts GLUT1 trafficking and glucose uptake. Biochimie. 174, 18\u201329 (2020)","journal-title":"Biochimie"},{"key":"1259_CR29","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1016\/j.jconrel.2024.05.025","volume":"371","author":"B Kang","year":"2024","unstructured":"B. Kang, H. Wang, H. Jing, Y. Dou, S. Krizkova, Z. Heger et al., Golgi-customized Trojan horse nanodiamonds impair GLUT1 plasma membrane localization and inhibit tumor glycolysis. J. Controlled Release. 371, 338\u2013350 (2024)","journal-title":"J. Controlled Release"},{"issue":"3","key":"1259_CR30","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1016\/0014-5793(93)80129-I","volume":"324","author":"T Asano","year":"2001","unstructured":"T. Asano, K. Takata, H. Katagiri, H. Ishihara, K. Inukai, M. Anai et al., The role of N-glycosylation in the targeting and stability of GLUT1 glucose transporter. FEBS Lett. 324(3), 258\u2013261 (2001)","journal-title":"FEBS Lett."},{"issue":"3","key":"1259_CR31","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1016\/j.bbrc.2007.02.025","volume":"355","author":"W Roach","year":"2007","unstructured":"W. Roach, M. Plomann, PACSIN3 overexpression increases adipocyte glucose transport through GLUT1. Biochem. Biophys. Res. Commun. 355(3), 745\u2013750 (2007)","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"15","key":"1259_CR32","doi-asserted-by":"publisher","first-page":"3077","DOI":"10.1242\/jcs.01290","volume":"117","author":"MM Kessels","year":"2004","unstructured":"M.M. Kessels, B. Qualmann, The syndapin protein family: linking membrane trafficking with the cytoskeleton. J. Cell Sci. 117(15), 3077\u20133086 (2004)","journal-title":"J. Cell Sci."},{"key":"1259_CR33","doi-asserted-by":"crossref","unstructured":"V. Dumont, S. Lehtonen, PACSIN proteins in vivo: Roles in development and physiology. Acta Physiol. 234 (3), (2022)","DOI":"10.1111\/apha.13783"},{"issue":"W1","key":"1259_CR34","doi-asserted-by":"publisher","first-page":"W420","DOI":"10.1093\/nar\/gkac373","volume":"50","author":"Y Xie","year":"2022","unstructured":"Y. Xie, H. Li, X. Luo, H. Li, Q. Gao, L. Zhang et al., IBS 2.0: an upgraded illustrator for the visualization of biological sequences. Nucleic Acids Res. 50(W1), W420\u2013W426 (2022)","journal-title":"Nucleic Acids Res."},{"issue":"6","key":"1259_CR35","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1016\/j.devcel.2005.11.005","volume":"9","author":"T Itoh","year":"2005","unstructured":"T. Itoh, K.S. Erdmann, A. Roux, B. Habermann, H. Werner, P. De Camilli, Dynamin and the Actin Cytoskeleton Cooperatively Regulate Plasma Membrane Invagination by BAR and F-BAR Proteins. Dev. Cell. 9(6), 791\u2013804 (2005)","journal-title":"Dev. Cell"},{"key":"1259_CR36","doi-asserted-by":"crossref","unstructured":"Q. Wang, M.V.A.S. Navarro, G. Peng, E. Molinelli, S. Lin Goh, B.L. Judson et al., Molecular mechanism of membrane constriction and tubulation mediated by the F-BAR protein Pacsin\/Syndapin. Proceedings of the National Academy of Sciences. 106 (31), 12700\u201312705 (2009)","DOI":"10.1073\/pnas.0902974106"},{"key":"1259_CR37","doi-asserted-by":"crossref","unstructured":"S. Guo, C. Zhang, H. Zeng, Y. Xia, C. Weng, Y. Deng et al., Glycolysis maintains AMPK activation in sorafenib-induced Warburg effect. Mol. Metabolism 77 (2023)","DOI":"10.1016\/j.molmet.2023.101796"},{"key":"1259_CR38","doi-asserted-by":"crossref","unstructured":"F. Suk, C. Wu, C. Fang, T. Chen, Y. Liao, \u03b2-HB treatment reverses sorafenib resistance by shifting glycolysis\u2013lactate metabolism in HCC. Biomed. Pharmacother. 166 (2023)","DOI":"10.1016\/j.biopha.2023.115293"},{"issue":"19","key":"1259_CR39","doi-asserted-by":"publisher","first-page":"7099","DOI":"10.1158\/0008-5472.CAN-04-1443","volume":"64","author":"SM Wilhelm","year":"2004","unstructured":"S.M. Wilhelm, C. Carter, L. Tang, D. Wilkie, A. McNabola, H. Rong et al., BAY 43-9006 Exhibits Broad Spectrum Oral Antitumor Activity and Targets the RAF\/MEK\/ERK Pathway and Receptor Tyrosine Kinases Involved in Tumor Progression and Angiogenesis. Cancer Res. 64(19), 7099\u20137109 (2004)","journal-title":"Cancer Res."},{"key":"1259_CR40","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/j.biopha.2018.09.031","volume":"108","author":"C Cheng","year":"2018","unstructured":"C. Cheng, Z. Xie, Y. Li, J. Wang, C. Qin, Y. Zhang, PTBP1 knockdown overcomes the resistance to vincristine and oxaliplatin in drug-resistant colon cancer cells through regulation of glycolysis. Biomed. Pharmacother. 108, 194\u2013200 (2018)","journal-title":"Biomed. Pharmacother."},{"key":"1259_CR41","doi-asserted-by":"crossref","unstructured":"C. Chelakkot, V.S. Chelakkot, Y. Shin, K. Song, Modulating Glycolysis to Improve Cancer Therapy. Int. J. Mol. Sci. 24 (3), (2023)","DOI":"10.3390\/ijms24032606"},{"key":"1259_CR42","doi-asserted-by":"crossref","unstructured":"C. Zhu, X. Chen, T. Liu, L. Cheng, W. Cheng, P. Cheng et al., Hexosaminidase B-driven cancer cell-macrophage co-dependency promotes glycolysis addiction and tumorigenesis in glioblastoma. Nat. Commun. 15 (1), (2024)","DOI":"10.1038\/s41467-024-52888-0"},{"issue":"8021","key":"1259_CR43","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1038\/s41586-024-07620-9","volume":"631","author":"H Chen","year":"2024","unstructured":"H. Chen, Y. Li, H. Li, X. Chen, H. Fu, D. Mao et al., NBS1 lactylation is required for efficient DNA repair and chemotherapy resistance. Nature. 631(8021), 663\u2013669 (2024)","journal-title":"Nature"},{"key":"1259_CR44","doi-asserted-by":"crossref","unstructured":"Y. Pang, Y. Lin, X. Wang, J. Wang, Q. Liu, N. Ding et al., Inhibition of abnormally activated HIF-1\u03b1-GLUT1\/3-glycolysis pathway enhances the sensitivity of hepatocellular carcinoma to 5-caffeoylquinic acid and its derivatives. Eur. J. Pharmacol. 920 (2022)","DOI":"10.1016\/j.ejphar.2022.174844"},{"issue":"2","key":"1259_CR45","doi-asserted-by":"publisher","first-page":"a016774","DOI":"10.1101\/cshperspect.a016774","volume":"6","author":"C Burd","year":"2014","unstructured":"C. Burd, P.J. Cullen, Retromer: A Master Conductor of Endosome Sorting. Cold Spring Harb. Perspect. Biol. 6(2), a016774\u2013a016774 (2014)","journal-title":"Cold Spring Harb. Perspect. Biol."},{"issue":"11","key":"1259_CR46","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1038\/s41580-018-0053-7","volume":"19","author":"PJ Cullen","year":"2018","unstructured":"P.J. Cullen, F. Steinberg, To degrade or not to degrade: mechanisms and significance of endocytic recycling. Nat. Rev. Mol. Cell Biol. 19(11), 679\u2013696 (2018)","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"8","key":"1259_CR47","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1111\/tra.12574","volume":"19","author":"J Wang","year":"2018","unstructured":"J. Wang, A. Fedoseienko, B. Chen, E. Burstein, D. Jia, D.D. Billadeau, Endosomal receptor trafficking: Retromer and beyond. Traffic. 19(8), 578\u2013590 (2018)","journal-title":"Traffic"},{"issue":"9","key":"1259_CR48","doi-asserted-by":"publisher","first-page":"2155","DOI":"10.1111\/liv.12818","volume":"35","author":"JW Park","year":"2015","unstructured":"J.W. Park, M. Chen, M. Colombo, L.R. Roberts, M. Schwartz, P.J. Chen et al., Global patterns of hepatocellular carcinoma management from diagnosis to death: the BRIDGE Study. Liver Int. 35(9), 2155\u20132166 (2015)","journal-title":"Liver Int."},{"issue":"4","key":"1259_CR49","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1056\/NEJMoa0708857","volume":"359","author":"JM Llovet","year":"2008","unstructured":"J.M. Llovet, S. Ricci, V. Mazzaferro, P. Hilgard, E. Gane, J.F. Blanc et al., Sorafenib in advanced hepatocellular carcinoma. N Engl. J. Med. 359(4), 378\u2013390 (2008)","journal-title":"N Engl. J. Med."},{"key":"1259_CR50","doi-asserted-by":"publisher","first-page":"104765","DOI":"10.1016\/j.critrevonc.2025.104765","volume":"212","author":"EH Yousef","year":"2025","unstructured":"E.H. Yousef, A.M. El Gayar, N.F.A. El-Magd, Insights into Sorafenib resistance in hepatocellular carcinoma: Mechanisms and therapeutic aspects. Crit. Rev. Oncol. Hematol. 212, 104765 (2025)","journal-title":"Crit. Rev. Oncol. Hematol."}],"container-title":["Cellular Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13402-026-01259-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13402-026-01259-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13402-026-01259-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T02:05:52Z","timestamp":1791252352000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13402-026-01259-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,11]]},"references-count":50,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2026,10]]}},"alternative-id":["1259"],"URL":"https:\/\/doi.org\/10.1007\/s13402-026-01259-6","relation":{},"ISSN":["2211-3436"],"issn-type":[{"value":"2211-3436","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,11]]},"assertion":[{"value":"11 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The TMA chip HLivH180Su09 was reviewed and approved by the Ethics Committee of Shanghai Outdo Biotech Company (Approval No. YB M-05-02). All procedures involving human participants were performed in accordance with the ethical standards of the institutional and national research committee and with the 1964 Helsinki Declaration and its later amendments. All animal experiments were approved by the Animal Ethics Committee of West China Hospital (Approval No. IACUC-20241122010).","order":1,"name":"Ethics","label":"Compliance with ethical standards","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"131"}}